Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Lord

Showing results (161-170 of 175) with videos related to

Pageof 18
Sort By:
Journal of Virology|December 23, 2004
Novel adeno-associated virus vector vaccine restricts replication of simian immunodeficiency virus in macaquesPhilip R Johnson, Bruce C Schnepp, Mary J Connell, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Clinical effects of human macrophage inflammatory protein-1 alpha MIP-1 alpha (LD78) administration to humans: a phase I study in cancer patients and normal healthy volunteers with the genetically engineered variant, BB-10010E Marshall, A H Howell, R Powles, et al.
Journal of Virology|May 22, 2002
Prior vaccination increases the epitopic breadth of the cytotoxic T-lymphocyte response that evolves in rhesus monkeys following a simian-human immunodeficiency virus infectionSampa Santra, Dan H Barouch, Marcelo J Kuroda, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 19, 1997
Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccinationN L Letvin, D C Montefiori, Y Yasutomi, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|May 26, 2006
Multidisciplinary team management is associated with improved outcomes after surgery for esophageal cancerM R Stephens, W G Lewis, A E Brewster, et al.
Stem Cells (Dayton, Ohio)|December 1, 1998
CD34+AC133+ cells isolated from cord blood are highly enriched in long-term culture-initiating cells, NOD/SCID-repopulating cells and dendritic cell progenitorsE A de Wynter, D Buck, C Hart, et al.
The Journal of Biological Chemistry|October 4, 2006
Analysis of human phagocyte flavocytochrome b(558) by mass spectrometryRoss M Taylor, Danas Baniulis, James B Burritt, et al.
Blood|December 15, 1995
BB-10010: an active variant of human macrophage inflammatory protein-1 alpha with improved pharmaceutical propertiesM G Hunter, L Bawden, D Brotherton, et al.
Journal of Virology|April 29, 2005
Replication-defective adenovirus serotype 5 vectors elicit durable cellular and humoral immune responses in nonhuman primatesSampa Santra, Michael S Seaman, Ling Xu, et al.
Blood|August 26, 1998
A randomized phase-II study of BB-10010 (macrophage inflammatory protein- 1alpha) in patients with advanced breast cancer receiving 5-fluorouracil, adriamycin, and cyclophosphamide chemotherapyM J Clemons, E Marshall, J Dürig, et al.
Pageof 18

Showing results (161-170 of 175) with videos related to

Sort By:
Pageof 18
Journal of Virology|December 23, 2004
Novel adeno-associated virus vector vaccine restricts replication of simian immunodeficiency virus in macaquesPhilip R Johnson, Bruce C Schnepp, Mary J Connell, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Clinical effects of human macrophage inflammatory protein-1 alpha MIP-1 alpha (LD78) administration to humans: a phase I study in cancer patients and normal healthy volunteers with the genetically engineered variant, BB-10010E Marshall, A H Howell, R Powles, et al.
Journal of Virology|May 22, 2002
Prior vaccination increases the epitopic breadth of the cytotoxic T-lymphocyte response that evolves in rhesus monkeys following a simian-human immunodeficiency virus infectionSampa Santra, Dan H Barouch, Marcelo J Kuroda, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 19, 1997
Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccinationN L Letvin, D C Montefiori, Y Yasutomi, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|May 26, 2006
Multidisciplinary team management is associated with improved outcomes after surgery for esophageal cancerM R Stephens, W G Lewis, A E Brewster, et al.
Stem Cells (Dayton, Ohio)|December 1, 1998
CD34+AC133+ cells isolated from cord blood are highly enriched in long-term culture-initiating cells, NOD/SCID-repopulating cells and dendritic cell progenitorsE A de Wynter, D Buck, C Hart, et al.
The Journal of Biological Chemistry|October 4, 2006
Analysis of human phagocyte flavocytochrome b(558) by mass spectrometryRoss M Taylor, Danas Baniulis, James B Burritt, et al.
Blood|December 15, 1995
BB-10010: an active variant of human macrophage inflammatory protein-1 alpha with improved pharmaceutical propertiesM G Hunter, L Bawden, D Brotherton, et al.
Journal of Virology|April 29, 2005
Replication-defective adenovirus serotype 5 vectors elicit durable cellular and humoral immune responses in nonhuman primatesSampa Santra, Michael S Seaman, Ling Xu, et al.
Blood|August 26, 1998
A randomized phase-II study of BB-10010 (macrophage inflammatory protein- 1alpha) in patients with advanced breast cancer receiving 5-fluorouracil, adriamycin, and cyclophosphamide chemotherapyM J Clemons, E Marshall, J Dürig, et al.
Pageof 18